Go Pro
NASDAQ:MLEC

Moolec Science Q1 2025 Earnings Report

Moolec Science logo
$7.65 -0.32 (-4.02%)
As of 10:07 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Moolec Science EPS Results

Actual EPS
-$7.50
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Moolec Science Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Moolec Science Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Moolec Science Earnings Headlines

MLEC Share News Today
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel
See More Moolec Science Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Moolec Science? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Moolec Science and other key companies, straight to your email.

About Moolec Science

Moolec Science (NASDAQ:MLEC), a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.

View Moolec Science Profile